{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:31:52Z","timestamp":1785717112765,"version":"3.56.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Verein zur F\u00f6rderung von H\u00e4matologie"},{"name":"Onkologie und Immunologie Innsbruck"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine the association of cardiovascular atherosclerotic plaque monosodium urate deposits with the occurrence of major cardiovascular events in gout and hyperuricemia patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study included patients with clinically suspicion of gout, who performed a dual energy computed tomography of the affected limb and thorax between 1 June 2012 and 5 December 2019. Clinical and laboratory parameters were retrieved from patients\u2019 charts. Established cardiovascular risk factors were evaluated. Medical history review identified the presence of major adverse cardiac events with a median follow-up time of 33\u2009months (range 0\u2013108\u2009months) after the performed computed tomography scan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Full data sets were available for 189 patients: 131 (69.3%) gout patients, 40 (21.2%) hyperuricemia patients and 18 (9.5%) controls. Patients with cardiovascular monosodium urate deposits (n\u2009=\u200985\/189, 45%) revealed increased serum acute phase reactants, uric acid levels and calcium scores in computed tomography compared with patients without cardiovascular monosodium urate deposits. Major adverse cardiac events were observed in 35 patients (18.5%) with a higher prevalence in those patients revealing cardiovascular monosodium urate deposits (n\u2009=\u200922\/85, 25.9%) compared with those without cardiovascular monosodium urate deposits (n\u2009=\u200913\/104, 12.5%, OR 2.4, P\u2009=\u20090.018).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This is the first study demonstrating the higher hazard of major adverse cardiac events in patients with dual energy computed tomography-verified cardiovascular monosodium urate deposits. The higher prevalence of cardiac events in patients with cardiovascular monosodium urate deposits may facilitate risk stratification of gout patients, as classical cardiovascular risk scores or laboratory markers fail in their proper identification.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae240","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T16:05:36Z","timestamp":1713888336000},"page":"1443-1447","source":"Crossref","is-referenced-by-count":15,"title":["Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques"],"prefix":"10.1093","volume":"64","author":[{"given":"Julia","family":"Held","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Medical University Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schwabl","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-1030","authenticated-orcid":false,"given":"David","family":"Haschka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Medical University Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Maier","sequence":"additional","affiliation":[{"name":"Institute of Medical Statistics and Informatics, Medical University of Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6755-4399","authenticated-orcid":false,"given":"Gudrun","family":"Feuchtner","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlig","family":"Widmann","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3137-8834","authenticated-orcid":false,"given":"Christina","family":"Duftner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Medical University Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0709-2158","authenticated-orcid":false,"given":"G\u00fcnter","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II, Medical University Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Klauser","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University Innsbruck , Innsbruck,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"2025030500181392200_keae240-B1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00296-021-04876-6","article-title":"The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis","volume":"41","author":"Cox","year":"2021","journal-title":"Rheumatol Int"},{"key":"2025030500181392200_keae240-B2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.27356","article-title":"Cellular characterization of the gouty tophus: a quantitative analysis","volume":"62","author":"Dalbeth","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025030500181392200_keae240-B3","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2025030500181392200_keae240-B4","doi-asserted-by":"crossref","first-page":"649505","DOI":"10.3389\/fmed.2021.649505","article-title":"Urate crystals; beyond joints","volume":"8","author":"Ahmad","year":"2021","journal-title":"Front Med"},{"key":"2025030500181392200_keae240-B5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2022.9165","article-title":"Cardiovascular events and gout flares","volume":"328","author":"Anderson","year":"2022","journal-title":"JAMA"},{"key":"2025030500181392200_keae240-B6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/rheumatology\/kep364","article-title":"Gout: an independent risk factor for all-cause and cardiovascular mortality","volume":"49","author":"Kuo","year":"2009","journal-title":"Rheumatology"},{"key":"2025030500181392200_keae240-B7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","article-title":"Improving cardiovascular and renal outcomes in gout: what should we target?","volume":"10","author":"Richette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2025030500181392200_keae240-B8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/annrheumdis-2014-206432","article-title":"When gout goes to the heart: does gout equal a cardiovascular disease risk factor?","volume":"74","author":"Singh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025030500181392200_keae240-B9","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1093\/rheumatology\/keaa920","article-title":"Crystal deposition measured with dual-energy computed tomography: association with mortality and cardiovascular risks in gout","volume":"60","author":"Marty-An\u00e9","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"2025030500181392200_keae240-B10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jamacardio.2019.3201","article-title":"Dual-energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout","volume":"4","author":"Klauser","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025030500181392200_keae240-B11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jacc.2007.10.034","article-title":"The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention","volume":"51","author":"Kip","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025030500181392200_keae240-B12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025030500181392200_keae240-B13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jamacardio.2019.5807","article-title":"Identification of cardiovascular monosodium urate crystal deposition in patients with gout using dual-energy computed tomography\u2014reply","volume":"5","author":"Halpern","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2025030500181392200_keae240-B14","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"2025030500181392200_keae240-B15","doi-asserted-by":"crossref","first-page":"e012219","DOI":"10.1161\/JAHA.119.012219","article-title":"Novel insights into the NLRP 3 inflammasome in atherosclerosis","volume":"8","author":"Jin","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025030500181392200_keae240-B16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0021-9150(94)90131-7","article-title":"Increased concentrations of neopterin in carotid atherosclerosis","volume":"106","author":"Weiss","year":"1994","journal-title":"Atherosclerosis"},{"key":"2025030500181392200_keae240-B17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCULATIONAHA.113.002714","article-title":"Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility","volume":"128","author":"Xiao","year":"2013","journal-title":"Circulation"},{"key":"2025030500181392200_keae240-B18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New Engl J Med"},{"key":"2025030500181392200_keae240-B19","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/j.amjmed.2020.02.034","article-title":"Coronary artery calcium and the age-specific competing risk of cardiovascular versus cancer mortality: the coronary artery calcium consortium","volume":"133","author":"Whelton","year":"2020","journal-title":"Am J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae240\/57807710\/keae240.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1443\/57807710\/keae240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1443\/57807710\/keae240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:20:45Z","timestamp":1741134045000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/3\/1443\/7656786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,23]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae240","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,4,23]]}}}